Last reviewed · How we verify
NCT05641441
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
trial testing Stereotactic radiosurgery in Vestibular Schwannoma in 258 participants. Currently enrolling.
15 November 2030
Quick facts
| Lead sponsor | University Hospital, Geneva |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 258 |
| Start date | 24 January 2023 |
| Primary completion | 15 November 2030 |
| Estimated completion | 15 November 2030 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Stereotactic radiosurgery
Conditions studied
- Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
- Ototoxicity — all drugs for Ototoxicity →
Sponsor
University Hospital, Geneva
Who can join
18 and older, any sex, with Vestibular Schwannoma or Ototoxicity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to study the impact of stereotactic radiosurgery, for the treatment of vestibular Schwannoma, on the cochlear, vestibular, gustatory, and facial nerve functions and compare it with a conservatively treated group. The predictive value of radiological tumor characteristics on hearing preservation and vestibular function will be also evaluated. Additionally, the investigators will invite patients with vestibular Schwannoma to fill out questionnaires to assess their quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05641441
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stereotactic radiosurgery
Trials testing the same drug.
- NCT06466720 — Measuring and Mapping Cognitive Decline After Brain Radiosurgery · recruiting
- NCT05177185 — Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnife · Phase 2 · unknown
- NCT05270707 — HyperArc Registry Study · completed
- NCT04785521 — Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery · active not recruiting
- NCT02886572 — SIMT Stereotactic Radiosurgery Outcomes Study · NA · completed
Other recruiting trials for Vestibular Schwannoma
Currently open trials in the same condition.
- NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
- NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
- NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
- NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
- NCT05622344 — StableEyes With Active Neurofeedback · NA · recruiting
Other University Hospital, Geneva trials
Trials by the same sponsor.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
- NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
- NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
- NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05641441 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
- Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641441.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing